Bentham Science Logo

Track Your Manuscript:


Current Drug Targets

Volume 21, 16 Issues, 2020
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Current Drug Targets, Volume 18 - Number 14

Review Article


Review Article

Recent Advances in Nanosystems and Strategies for Managing Leishmaniasis

, 18(14): 1598 - 1621

Rudra Vaghela*, Parthasarathi K. Kulkarni, Riyaz Ali M. Osmani, Rohit R. Bhosale and Naga Sravan Kumar Varma V


DOI: 10.2174/1389450117666160401124133



Review Article


Review Article

Hydrogen Sulfide and Inflammatory Joint Diseases

, 18(14): 1641 - 1652

Elena F. Burguera*, Rosa Meijide-Failde and Francisco J. Blanco*


DOI: 10.2174/1389450117666160829112824



Review Article

The Smart Programmable CRISPR Technology: A Next Generation Genome Editing Tool for Investigators

, 18(14): 1653 - 1663

Chiranjib Chakraborty, Seong Lin Teoh and Srijit Das*


DOI: 10.2174/1389450117666160527142321



Review Article




Editor-in-Chief

Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)

View Full Editorial Board

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.63

Advertisement

STATISTICS AND DATA PRESENTATIONCovid Resource CenterCoronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog